Generics on Their Mind | GenomeWeb

Sanofi-Aventis will be expanding into generics, says the Wall Street Journal, while cutting its research and development. The generic group will be reshuffled to focus on emerging markets where drug sales are on the rise. The Health Blog adds that Sanofi recently bought two Latin American generic-drug companies as well as a Czech one.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.